Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Sarcoidosis associated with neuromyelitis optica.
Toll-like receptor-9 in Spanish multiple sclerosis patients: an association with the gender.
Brain atrophy in natalizumab-treated patients: A 3-year follow-up.
A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis.
Functioning assessment vs. conventional medical assessment: a comparative study on health professionals' clinical decision-making and the fit with patient's own perspective of health.
Molecular epidemiology of JCV genotypes in patients and healthy subjects from Northern Italy.
Any role for probiotics in the therapy or prevention of autoimmune diseases? Up-to-date review.
New insights in the pathogenesis of multiple sclerosis-role of acrolein in neuronal and myelin damage.
Botulinum neurotoxin-A treatment of lower urinary tract symptoms in multiple sclerosis.
Longitudinal evaluation of cognitive functioning in pediatric multiple sclerosis: report from the US Pediatric Multiple Sclerosis Network.
Disease modifying therapies in multiple sclerosis: Could a baseline thyroid check-up drive the therapeutic choice between interferon-β and glatiramer acetate?
A GPBAR1 (TGR5) Small Molecule Agonist Shows Specific Inhibitory Effects on Myeloid Cell Activation In Vitro and Reduces Experimental Autoimmune Encephalitis (EAE) In Vivo.
Clustering of autoimmune diseases in patients with rosacea.
Toxic hepatitis after concomitant interferon beta and aloe vera treatment in a patient with multiple sclerosis: A case report.
Agent based modeling of the effects of potential treatments over the blood-brain barrier in multiple sclerosis.
How strong is the relationship between glaucoma, the retinal nerve fibre layer, and neurodegenerative diseases such as Alzheimer's disease and multiple sclerosis?
JAML mediates monocyte and CD8 T cell migration across the brain endothelium.
The Gender Gap in Multiple Sclerosis: Intersection of Science and Society.
BG-12 in Multiple Sclerosis.
Therapeutic Decisions in Multiple Sclerosis: Moving Beyond Efficacy.
Risk for nevus transformation and melanoma proliferation and invasion during natalizumab treatment: four years of dermoscopic follow-up with immunohistological studies and proliferation and invasion assays.
Earlier and more frequent diagnosis of multiple sclerosis using the McDonald criteria.
Modifiable environmental factors in multiple sclerosis.
Predicting outcome in clinically isolated syndrome using machine learning.
Autophagy and neurodegeneration.

Pages